LeMaitre Vascular Gross Margin 2010-2025 | LMAT
Current and historical gross margin for LeMaitre Vascular (LMAT) over the last 10 years. The current gross profit margin for LeMaitre Vascular as of June 30, 2025 is %.
| LeMaitre Vascular Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $0.24B | $0.16B | 68.94% |
| 2025-03-31 | $0.23B | $0.16B | 68.28% |
| 2024-12-31 | $0.22B | $0.15B | 68.64% |
| 2024-09-30 | $0.21B | $0.15B | 68.08% |
| 2024-06-30 | $0.21B | $0.14B | 67.80% |
| 2024-03-31 | $0.20B | $0.13B | 66.83% |
| 2023-12-31 | $0.19B | $0.13B | 65.80% |
| 2023-09-30 | $0.19B | $0.12B | 64.86% |
| 2023-06-30 | $0.18B | $0.11B | 64.41% |
| 2023-03-31 | $0.17B | $0.11B | 65.09% |
| 2022-12-31 | $0.16B | $0.11B | 64.81% |
| 2022-09-30 | $0.16B | $0.11B | 65.22% |
| 2022-06-30 | $0.16B | $0.11B | 65.63% |
| 2022-03-31 | $0.16B | $0.10B | 65.41% |
| 2021-12-31 | $0.16B | $0.10B | 65.81% |
| 2021-09-30 | $0.15B | $0.10B | 65.36% |
| 2021-06-30 | $0.15B | $0.10B | 64.90% |
| 2021-03-31 | $0.14B | $0.09B | 65.19% |
| 2020-12-31 | $0.13B | $0.08B | 64.62% |
| 2020-09-30 | $0.12B | $0.08B | 65.57% |
| 2020-06-30 | $0.12B | $0.08B | 66.96% |
| 2020-03-31 | $0.12B | $0.08B | 67.23% |
| 2019-12-31 | $0.12B | $0.08B | 68.10% |
| 2019-09-30 | $0.11B | $0.08B | 68.42% |
| 2019-06-30 | $0.11B | $0.08B | 68.81% |
| 2019-03-31 | $0.11B | $0.07B | 69.16% |
| 2018-12-31 | $0.11B | $0.07B | 69.52% |
| 2018-09-30 | $0.10B | $0.07B | 69.90% |
| 2018-06-30 | $0.10B | $0.07B | 70.19% |
| 2018-03-31 | $0.10B | $0.07B | 69.90% |
| 2017-12-31 | $0.10B | $0.07B | 70.30% |
| 2017-09-30 | $0.10B | $0.07B | 70.41% |
| 2017-06-30 | $0.10B | $0.07B | 70.83% |
| 2017-03-31 | $0.09B | $0.07B | 70.65% |
| 2016-12-31 | $0.09B | $0.06B | 70.45% |
| 2016-09-30 | $0.09B | $0.06B | 70.59% |
| 2016-06-30 | $0.08B | $0.06B | 70.37% |
| 2016-03-31 | $0.08B | $0.06B | 69.62% |
| 2015-12-31 | $0.08B | $0.05B | 69.23% |
| 2015-09-30 | $0.08B | $0.05B | 68.83% |
| 2015-06-30 | $0.08B | $0.05B | 67.11% |
| 2015-03-31 | $0.07B | $0.05B | 67.57% |
| 2014-12-31 | $0.07B | $0.05B | 66.67% |
| 2014-09-30 | $0.07B | $0.05B | 66.20% |
| 2014-06-30 | $0.07B | $0.05B | 67.65% |
| 2014-03-31 | $0.07B | $0.05B | 68.18% |
| 2013-12-31 | $0.06B | $0.05B | 70.31% |
| 2013-09-30 | $0.06B | $0.04B | 70.49% |
| 2013-06-30 | $0.06B | $0.04B | 70.00% |
| 2013-03-31 | $0.06B | $0.04B | 72.41% |
| 2012-12-31 | $0.06B | $0.04B | 71.93% |
| 2012-09-30 | $0.06B | $0.04B | 74.55% |
| 2012-06-30 | $0.06B | $0.04B | 73.21% |
| 2012-03-31 | $0.06B | $0.04B | 70.18% |
| 2011-12-31 | $0.06B | $0.04B | 68.97% |
| 2011-09-30 | $0.06B | $0.04B | 67.80% |
| 2011-06-30 | $0.06B | $0.04B | 68.97% |
| 2011-03-31 | $0.06B | $0.04B | 71.93% |
| 2010-12-31 | $0.06B | $0.04B | 73.21% |
| 2010-09-30 | $0.06B | $0.04B | 73.21% |
| 2010-06-30 | $0.06B | $0.04B | 74.55% |
| 2010-03-31 | $0.05B | $0.04B | 72.22% |
| 2009-12-31 | $0.05B | $0.04B | 72.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.209B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.514B | 26.91 |
| Boston Scientific (BSX) | United States | $155.747B | 37.14 |
| Stryker (SYK) | United States | $149.436B | 30.42 |
| EssilorLuxottica (ESLOY) | France | $144.168B | 0.00 |
| Medtronic (MDT) | Ireland | $117.977B | 16.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.715B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.412B | 24.82 |
| ResMed (RMD) | United States | $41.845B | 29.93 |
| GE HealthCare Technologies (GEHC) | United States | $34.055B | 16.01 |
| Agilent Technologies (A) | United States | $33.846B | 22.07 |
| Koninklijke Philips (PHG) | Netherlands | $26.577B | 17.58 |
| Terumo (TRUMY) | Japan | $26.206B | 31.05 |
| Insulet (PODD) | United States | $23.159B | 77.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.260B | 13.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.271B | 0.00 |
| Baxter (BAX) | United States | $12.615B | 9.75 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.048B | 29.56 |
| Lantheus Holdings (LNTH) | United States | $3.819B | 10.32 |
| Envista Holdings (NVST) | United States | $3.510B | 24.56 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.272B | 8.17 |
| Prestige Consumer Healthcare (PBH) | United States | $3.231B | 14.34 |
| ICU Medical (ICUI) | United States | $3.106B | 21.15 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| Acuren (TIC) | United States | $2.126B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.005B | 0.00 |
| AtriCure (ATRC) | United States | $1.881B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.877B | 11.82 |
| Green Thumb Industries (GTBIF) | United States | $1.869B | 80.25 |
| Tilray Brands (TLRY) | Canada | $1.530B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.295B | 16.55 |
| AdaptHealth (AHCO) | United States | $1.249B | 17.75 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| InMode (INMD) | Israel | $0.921B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.910B | 0.00 |
| Valneva SE (VALN) | France | $0.802B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.648B | 0.00 |
| SNDL (SNDL) | Canada | $0.631B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.613B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.593B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.505B | 0.00 |
| Evolus (EOLS) | United States | $0.481B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.473B | 16.29 |
| CeriBell (CBLL) | United States | $0.419B | 0.00 |
| Owens & Minor (OMI) | United States | $0.396B | 3.51 |
| Sanuwave Health (SNWV) | United States | $0.366B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.345B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Brainsway (BWAY) | Israel | $0.290B | 59.08 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.85 |
| TriSalus Life Sciences (TLSI) | United States | $0.246B | 0.00 |
| Cerus (CERS) | United States | $0.245B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.243B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.193B | 16.13 |
| FitLife Brands (FTLF) | United States | $0.171B | 21.05 |
| Biote (BTMD) | United States | $0.160B | 5.30 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.31 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.066B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.03 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.92 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.36 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |